The thresholds used for CRP (>60 mg/dL) and PCT (>2 ng/mL) were selected as markers of potential severe inflammation based on clinical practice rather than validated prognostic cut-offs for bacterial co-infection in influenza. The gene discussed is CRP; the disease is influenza.